Stock CVKD CADRENAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-03 EDT 		5-day change 1st Jan Change
0.497 USD +5.45% Intraday chart for Cadrenal Therapeutics, Inc. +21.04% -32.83%
05-09 Cadrenal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-09 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts CI

Chart calendar Cadrenal Therapeutics, Inc.

42d3ab273b4e2419f27f86d1d8dcdc.fYP1JXlkojvLgs7gYTTZkcD4dxuWUPpXTLhhX8z3Sdo.B-K7FysS9XKoyr6ILWOT0rqeJ3n0Er4SIPk2CI-9frNQ0YZEFh79aK6wjw~cbc2f386a35fdd51b4a36a04c04795fd

Upcoming events on Cadrenal Therapeutics, Inc.

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-16 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Cadrenal Therapeutics, Inc.

2024-05-30 12:30 Lytham Partners Spring Investor Conference
2024-05-09 09:00 Q1 2024 Earnings Release
2024-04-18 13:00 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-03-11 09:00 Q4 2023 Earnings Release
2024-03-03 Technology and Heart Failure Therapeutics Conference
2024-02-01 11:00 Lytham Partners Investor Select Conference
2023-12-04 16:00 Noble Capital Markets Emerging Growth Equity Conference
2023-11-08 Q3 2023 Earnings Release
2023-10-19 Annual General Meeting
2023-10-17 10:30 Lytham Partners Fall Investor Conference - Panel
2023-10-17 07:00 Lytham Partners Fall Investor Conference
2023-09-10 H.C. Wainwright Global Investment Conference
2023-08-10 09:00 Q2 2023 Earnings Release
2023-06-04 BIO International Convention
2023-05-18 14:00 Lytham Partners Spring Investor Conference
2023-05-18 09:00 Lytham Partners Spring Investor Conference
2023-05-10 09:00 Q1 2023 Earnings Release
2023-02-05 BIO CEO and Investor Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00


-7,63
-7,70
0.9%
-10,1

EBIT
Million USD		Released
Forecast
Spread 		0,00


-7,63
-7,64
0.15%
-8,22

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-8,36
-7,64
-9.36%
-7,97

Net income
Million USD		Released
Forecast
Spread 		-6,71


-8,36
-7,64
-9.36%
-7,97

EPS
USD		Released
Forecast
Spread 		-0,85


-0,62
-0,57
-8.77%
-0,36

Announcement Date30/03/2311/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread


-1,26
-1,30
2.83%		-1,76
-1,50
-17.08%
-2,10


-2,90


-3,40

EBIT
Million USD		Released
Forecast
Spread


-1,26
-1,26
-0.26%		-1,76
-1,43
-22.77%
-1,78


-2,30


-2,60

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-1,14
-1,17
2.3%		-1,66
-1,32
-26.49%
-1,70


-2,22


-2,60

Net income
Million USD		Released
Forecast
Spread 		-1,04


-1,14
-1,17
2.3%		-1,66
-1,32
-26.49%
-1,70


-2,22


-2,60

EPS
USD		Released
Forecast
Spread 		-0,07


-0,05
-0,08
37.5%		-0,10
-0,05
-100%
-0,09


-0,09


-0,11

Announcement Date09/11/2311/03/2409/05/24---

Upcoming sector events for Cadrenal Therapeutics, Inc.

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected)
2024-07-15 JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected)
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Cadrenal Therapeutics, Inc.

2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
2024-05-29 04:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-29 04:10 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 PFIZER LIMITED: Q4 2024 Earnings Release
2024-05-27 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
2024-05-27 08:10 ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Calendar Cadrenal Therapeutics, Inc.